Nonopioid Analgesia After Labral Surgery

Recruiting Phase 2 Phase 3 Interventional Study
Narcotic Use
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2/3
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
Henry Ford Health System · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Eligibility Criteria: Inclusion Criteria: * All adult patients over age 18 and scheduled for a primary or revision labral surgery Exclusion Criteria: * Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylen…
Contacts

Toufic R Jildeh, MD

517-230-8511

tjildeh1@hfhs.org

CONTACT